Objective:To investigate variations of plasma ET-1,TNF-α and liver function and its clinical significance in portal hypertensive patients with esophageal variceal hemorrhage. Methods:A total of 66 patients with portal hypertension admitted between June 2001 and June 2004 in the Third Xiangya Hospital of CentraSouth University were divided into 2 groups.The patients in groupⅠ(32 cases) were performed general therapy and those in GroupⅡ(34 cases) were performed the general therapy and ulinastatin after hemorrhage.The plasma ET-1 and TNF-α concentration were measured on the 1st,2nd,4th,7th,10th and 14th day and liver function determined on the 1st,7th and 14th day after the hemorrhage.Other 20 patients without the hemorrhage were served as the control group. Results:On the 7th and 14th day after hemorrhage,the levels of TBIL,ALT and AST were elevated firstly and then decreased in groupsⅠ and Ⅱ.The decreased of TBIL,ALT and AST levels was significantly faster in groupⅡ than in groupⅠ(P<0.05) on the 14th day after hemorrhage.On the 1st day after the hemorrhage the ET-1,TNF-α concentration was markedly increased in groupⅠandⅡ compared with the control group (P<0.01).Then it was gradually decreased on the 10th day after hemorrhage.The ET1,TNFα concentration in groupⅡ was decreased more rapidly than that in groupⅠon the 2nd,4th and 7th day after hemorrhage(P<0.05).Meanwhile the decreased index of ET-1 and TNF-α concentration was negatively correlated to increased index of TBIL in the 2 groups(P<0.05). Conclusion:The increased plasma ET-1,TNF-α in portal hypertensive patients with hemorrhage may contribute to liver injure.Ulinastatin can protect liver function by inhibiting ALT,AST,TBIL and ET-1,TNF-α level.